Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2019 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's own size, i.e., that what is happening now is disproportionately large relative to the company's smallness. Look for statements about current activity, demand, commitments, or wins that are large relative to the company's size. In the transcript, management discusses strong growth, record ARR, ARPS, etc. They mention specific large deals like Daiwa House, Ford, and EBAs. They also mention the acquisition of PlanGrid. But the question is about the company's current business being disproportionately large relative to its size. For example, if they say a single customer or contract is huge relative to revenue, or that they are handling volumes that would have been out of reach for a company of their size. Look for explicit contrasts. For instance, they mention "we hit a milestone of four million total subscriptions" and "twice the number of maintenance seats we had at the peak of the previous business model." That shows growth but not necessarily disproportion relative to company size. They mention "record growth in total ARR and total ARPS" and "highest growth quarter for both since we started our business model transition over four years ago." That indicates strong growth but not necessarily that the business is small relative to what's arriving. They mention "we had a strong showing for the entire offering, which helped us post 36% growth in cloud ARR" and "large customers like AECOM, Arcadis, Swinerton, and Layton have already started adopting our new platform." That's strong demand but not necessarily disproportion. They mention "we transitioned a major customer, Ford to an EBA" and "we expect a fourth [Indiscernible] increase in subscriptions as a result of our new EBA contract." That's a significant deal but not necessarily disproportionate relative to company size. They mention "we are expanding our capabilities in the construction space by acquiring PlanGrid" and "PlanGrid currently serves 12,000 customers and has approximately 120,000 paid users." That's an acquisition, not current business. The question is about the company's own current business being disproportionately large relative to its size.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.